Biological Variability of Transferrin Saturation and Unsaturated Iron-Binding Capacity

The American Journal of Medicine - Tập 120 - Trang 999.e1-999.e7 - 2007
Paul C. Adams1, David M. Reboussin2, Richard D. Press3, James C. Barton4, Ronald T. Acton5, Godfrey C. Moses6, Catherine Leiendecker-Foster7, Gordon D. McLaren8,9, Fitzroy W. Dawkins10, Victor R. Gordeuk10, Laura Lovato2, John H. Eckfeldt7
1Department of Medicine, University Hospital, London, Ontario, Canada
2Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC
3Department of Pathology, Oregon Health and Science University, Portland, OR
4Southern Iron Disorders Center, Birmingham, Ala
5Departments of Microbiology, Medicine, and Epidemiology and International Health, University of Alabama at Birmingham, Birmingham, Ala
6MDS Laboratories, Toronto, Ontario
7Department of Laboratory Medicine and Pathology, University of Minnesota, Minnesota, Minneapolis
8Veterans Affairs Long Beach Healthcare System, Long Beach, Calif
9Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Calif
10Department of Medicine, Howard University, Washington, DC

Tài liệu tham khảo

Pietrangelo, 2004, Hereditary hemochromatosis: a new look at an old disease, N Engl J Med, 350, 2383, 10.1056/NEJMra031573

Feder, 1996, A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis, Nat Genet, 13, 399, 10.1038/ng0896-399

Burke, 1998, Hereditary hemochromatosis: gene discovery and its implications for population-based screening, JAMA, 280, 172, 10.1001/jama.280.2.172

Beutler, 2002, Penetrance of the 845G to A (C282Y) HFE hereditary haemochromatosis mutation in the USA, Lancet, 359, 211, 10.1016/S0140-6736(02)07447-0

Whitlock, 2006, Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventative Services Task Force, Ann Intern Med, 145, 209, 10.7326/0003-4819-145-3-200608010-00009

Asberg, 2001, Screening for hemochromatosis—high prevalence and low morbidity in an unselected population of 65,238 persons, Scand J Gastroenterol, 36, 1108, 10.1080/003655201750422747

Adams, 2000, Non-expressing C282Y homozygotes for hemochromatosis: minority or majority of cases?, Mol Genet Metab, 71, 81, 10.1006/mgme.2000.3037

Andersen, 2004, Hemochromatosis mutations in the general population: iron overload progression rate, Blood, 103, 2914, 10.1182/blood-2003-10-3564

Yamashita, 2003, Natural history of the C282Y homozygote of the hemochromatosis gene (HFE) with a normal serum ferritin level, Clin Gastroenterol Hepatol, 1, 388, 10.1053/S1542-3565(03)00187-3

Tavill, 2001, Diagnosis and management of hemochromatosis, Hepatology, 33, 1321, 10.1053/jhep.2001.24783

Shaheen, 2003, Insurance, employment, and psychosocial consequences of a diagnosis of hereditary hemochromatosis in subjects without end-organ damage, Am J Gastroenterol, 98, 1175, 10.1111/j.1572-0241.2003.07405.x

Barash, 2000, Genetic discrimination and screening for hemochromatosis: then and now, Genet Test, 4, 213, 10.1089/10906570050114939

McLaren, 2003, Hemochromatosis and Iron Overload Screening (HEIRS) Study design for an evaluation of 100,000 primary care-based adults, Am J Med Sci, 325, 53, 10.1097/00000441-200302000-00001

Adams, 2005, Hemochromatosis and iron-overload screening in a racially diverse population, N Engl J Med, 352, 1769, 10.1056/NEJMoa041534

Barton, 1998, Management of hemochromatosis, Ann Intern Med, 129, 932, 10.7326/0003-4819-129-11_Part_2-199812011-00003

Adams, 1995, Screening blood donors for hereditary hemochromatosis: decision analysis model based on a thirty-year database, Gastroenterology, 109, 177, 10.1016/0016-5085(95)90283-X

Adams, 2005, Comparison of the unsaturated iron binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the HEIRS Study, Clin Chem, 51, 1048, 10.1373/clinchem.2005.048371

Dale, 2002, Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels, Clin Chem, 117, 802

Sinniah, 1969, Diurnal variations of the serum iron in normal subjects and in patients with haemochromatosis, Br J Haematol, 17, 351, 10.1111/j.1365-2141.1969.tb01381.x

Stengle, 1957, Diurnal/nocturnal variations of certain blood cell constituents in normal human subjects: plasma iron, siderophilin, bilirubin, copper, total serum protein and albumin, hemoglobin and hematocrit, Br J Haematol, 3, 117, 10.1111/j.1365-2141.1957.tb05778.x

Casale, 1981, Circadian rhythm of plasma iron, total iron binding capacity and serum ferritin in arteriosclerotic aged patients, Age Ageing, 10, 115, 10.1093/ageing/10.2.115

Guillygomarch, 2003, Circadian variations of transferrin saturation levels in iron-overloaded patients: implications for screening of C282Y-linked haemochromatosis, Br J Haematol, 120, 359, 10.1046/j.1365-2141.2003.04070.x

Edwards, 1989, Twenty-four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes, J Intern Med, 226, 373, 10.1111/j.1365-2796.1989.tb01411.x

Delatycki, 2005, Use of community genetic screening to prevent HFE-associated hereditary hemochromatosis, Lancet, 366, 316, 10.1016/S0140-6736(05)63012-7

Hall, 2005, Concerns in a primary care population about genetic discrimination by insurers, Genet Med, 7, 311, 10.1097/01.GIM.0000162874.58370.C0

Power, 2001, Psychosocial impact of genetic screening for hemochromatosis in population screening and referred patients, Genet Test, 5, 107, 10.1089/109065701753145556

Thông tin
Thông tin xuất bản

The American Journal of Medicine

Tập 120

999.e1-999.e7

Thông tin tác giả